Impact of neoadjuvant immunotherapy on postoperative complications after surgery for rectal cancer.

Matthew ShouDaniel Roy Sadek HabibKamran IdreesAlexander HawkinsMolly FordHanjoo LeeBaryalay KhanAimal Khan

Published in: Journal of surgical oncology (2024)

Neoadjuvant immunotherapy for rectal cancer is not associated with adverse surgical outcomes. This work can help clinicians optimize treatment protocols and move closer toward strategies tailored to specific patient profiles.

Keyphrases

rectal cancer
locally advanced
palliative care
squamous cell carcinoma
emergency department
radiation therapy
replacement therapy
adverse drug